Patent ID: 11856970
Assignee: CHR. HANSEN A/S/
Field: Biotechnology (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 0:
1. A method for inhibiting a bacterial colonization or bacterial infection by one or more of Staphylococcus pseudintermedius, Staphylococcus carnosus, Salmonella enterica, Salmonella Newport, Streptococcus canis, Escherichia coli, and Clostridium perfringens, the method comprising administering to an animal in need thereof an effective amount of a Bacillus subtilis strain deposited at Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, Braunschweig, Germany (DSMZ) under accession number DSM 32685, wherein strain DSM 32685:
(i) exhibits susceptibility to ampicillin, vancomycin, gentamicin, kanamycin, streptomycin, erythromycin, clindamycin, tetracycline, and chloramphenicol when tested under CLSI guidelines M07-A8 and M45-A2;
(ii) exhibits an inhibition zone of at least 1 mm for Staphylococcus pseudintermedius, Escherichia coli, and Salmonella enterica; 
(iii) reduces the growth rate of Streptococcus canis by at least one log10 growth in 24 hours; and
(iv) inhibits growth of Staphylococcus carnosus, Salmonella Newport, and Clostridium perfringens.